About the journal
Cell stem cell is a journal published by Elsevier BV in United States. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 9,080 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 1934-5909 · 1875-9777
- Country
- United States
- Access
- Not open access / not declared
- Declared publication charge
- 9,080 USD
- Declared peer-review model
- peer_review
- Official website
- http://www.cell.com/cell-stem-cell/home
Index listings
- MEDLINE · 2007-01-01
- PUBMED · 2007-06-07
- Indexing
- MEDLINE · PUBMED
- APC
- 9,080 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 163 days received→accepted — computed from PubMed (n=97)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
3841
Last recorded publication year
2026
h-index
373
i10-index
2564
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 94%
- ORCID iDs in current deposits
- 61%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101311472
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Pluripotent Stem Cells Research
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- CRISPR and Genetic Engineering
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Biomedical Ethics and Regulation
- Biomedical Ethics and Regulation
Show all subjects (50)
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Neurogenesis and neuroplasticity mechanisms
- Neurogenesis and neuroplasticity mechanisms
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Renal and related cancers
- Renal and related cancers
- Tissue Engineering and Regenerative Medicine
- Tissue Engineering and Regenerative Medicine
- Mesenchymal stem cell research
- Mesenchymal stem cell research
- 3D Printing in Biomedical Research
- 3D Printing in Biomedical Research
- Single-cell and spatial transcriptomics
- Single-cell and spatial transcriptomics
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Pancreatic function and diabetes
- Pancreatic function and diabetes
- Congenital heart defects research
- Congenital heart defects research
- Genomics and Chromatin Dynamics
- Genomics and Chromatin Dynamics
- CAR-T cell therapy research
- CAR-T cell therapy research
- Neonatal Respiratory Health Research
- Neonatal Respiratory Health Research
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- RNA Research and Splicing
- RNA Research and Splicing
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- RNA Interference and Gene Delivery
- Immune cells in cancer
- Immune cells in cancer
- RNA Interference and Gene Delivery
- Genetics, Aging, and Longevity in Model Organisms
- Genetics, Aging, and Longevity in Model Organisms
- Muscle Physiology and Disorders
- Muscle Physiology and Disorders
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ